Downregulation of S1PR1 expression has been shown to increase proliferative activity resulting in enhanced malignancy and poor survival of glioblastomas [52] while high-level expression of transcripts encoding ephrin-B2 has been reported as predictive of favourable disease outcome of neuroblastoma [53]. This evidence concerns the gene EFNB2 and glioblastoma.